title: Progesterone: the ultimate endometrial tumor suppressor.
abstract: The uterine endometrium is exquisitely sensitive to steroid hormones that act through well-described nuclear receptors. Estrogen drives epithelial proliferation, and progesterone inhibits growth and causes cell differentiation. The importance of progesterone as a key inhibitor of carcinogenesis is reflected by the observation that women who ovulate and produce progesterone almost never get endometrial cancer. In this review we describe seminal research findings that define progesterone as the major endometrial tumor suppressor. We discuss the genes and diverse signaling pathways that are controlled by progesterone through progesterone receptors (PRs) and also the multiple factors that regulate progesterone/PR activity. By defining these progesterone-regulated factors and pathways we identify the principal therapeutic opportunities to control the growth of endometrial cancer.
authors.affiliation: Department of Obstetrics & Gynecology and Holden Comprehensive Cancer Center,The University of Iowa, Iowa City, Iowa 52242, USA.
authors.forename: Shujie
authors.initials: S
authors.lastname: Yang
authors.forename: Kristina W
authors.initials: KW
authors.lastname: Thiel
authors.forename: Kimberly K
authors.initials: KK
authors.lastname: Leslie
mesh_terms: D016889:Endometrial Neoplasms / Q000188:drug therapy / Q000378:metabolism*; D005260:Female; D006801:Humans; D011374:Progesterone / Q000378:metabolism*; D011372:Progestins / Q000627:therapeutic use; D011980:Receptors, Progesterone / Q000378:metabolism
chemical_list: D011372:Progestins; D011980:Receptors, Progesterone; D011374:Progesterone